ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 97 filers reported holding ALX ONCOLOGY HLDGS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $19,750,000 | -73.9% | 918,908 | -10.4% | 0.01% | -75.8% |
| Q3 2021 | $75,744,000 | +13.2% | 1,025,399 | -16.2% | 0.03% | +13.8% |
| Q2 2021 | $66,911,000 | -31.4% | 1,223,613 | -10.8% | 0.03% | -35.6% |
| Q1 2021 | $97,534,000 | -28.1% | 1,371,876 | -15.7% | 0.04% | -28.6% |
| Q4 2020 | $135,690,000 | +736.5% | 1,628,199 | +278.8% | 0.06% | +687.5% |
| Q3 2020 | $16,221,000 | – | 429,802 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $163,929,000 | 36.34% |
| Logos Global Management LP | 3,011,352 | $50,892,000 | 6.60% |
| Vivo Capital, LLC | 4,220,048 | $71,319,000 | 4.91% |
| Samsara BioCapital, LLC | 262,786 | $4,441,000 | 1.12% |
| Cormorant Asset Management, LP | 712,079 | $12,034,000 | 0.92% |
| Pier Capital, LLC | 394,443 | $6,666,000 | 0.85% |
| Redmile Group, LLC | 772,397 | $13,054,000 | 0.41% |
| Artal Group S.A. | 500,000 | $8,450,000 | 0.35% |
| Nan Fung Group Holdings Ltd | 41,950 | $709,000 | 0.34% |
| Orbimed Advisors | 621,700 | $10,507,000 | 0.17% |